Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials.

Authors : Caparica R, Bruzzone M, Poggio F, Ceppi M, de Azambuja E, Lambertini M
Year : 2019
Journal : Breast Cancer Res Treat
Volume : 174
Pages : 27-37